• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia.

作者信息

Oshikawa Gaku, Kakihana Kazuhiko, Saito Makoto, Aoki Jun, Najima Yuho, Kobayashi Takeshi, Doki Noriko, Sakamaki Hisashi, Ohashi Kazuteru

机构信息

Division of Haematology, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan.

Divisions of Clinical Research Support, Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital, Tokyo, Japan.

出版信息

Br J Haematol. 2015 Jun;169(5):756-9. doi: 10.1111/bjh.13248. Epub 2014 Dec 17.

DOI:10.1111/bjh.13248
PMID:25522128
Abstract
摘要

相似文献

1
Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia.阿扎胞苷和吉妥珠单抗奥唑米星用于高危急性髓性白血病的移植后维持治疗。
Br J Haematol. 2015 Jun;169(5):756-9. doi: 10.1111/bjh.13248. Epub 2014 Dec 17.
2
Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia.在异基因干细胞移植前，使用吉妥珠单抗奥唑米星和阿糖胞苷进行细胞减灭术治疗复发/难治性急性髓系白血病。
Leuk Lymphoma. 2012 Oct;53(10):2085-8. doi: 10.3109/10428194.2011.603450. Epub 2011 Sep 6.
3
Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study.吉妥珠单抗奥佐米星联合伏立诺他和阿扎胞苷治疗复发或难治性老年急性髓系白血病的Ⅰ/Ⅱ期研究。
Haematologica. 2014 Jan;99(1):54-9. doi: 10.3324/haematol.2013.096545. Epub 2013 Oct 18.
4
Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia.地西他滨联合分次使用吉妥珠单抗奥唑米星治疗复发或难治性急性髓系白血病患者。
Am J Hematol. 2009 Sep;84(9):599-600. doi: 10.1002/ajh.21478.
5
[Gemtuzumab ozogamicin as monotherapy and combination therapy for acute myelogenous leukemia].
Rinsho Ketsueki. 2007 Jun;48(6):458-67.
6
Gemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia.
Br J Haematol. 2008 Sep;142(5):852-3. doi: 10.1111/j.1365-2141.2008.07247.x. Epub 2008 May 28.
7
Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly.低剂量吉妥珠单抗奥唑米星治疗老年复发性急性髓系白血病
Haematologica. 2003 Dec;88(12):ECR37.
8
Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.吉妥单抗奥佐米星免疫疗法在CD33+急性髓系白血病儿童患者中进行减低强度异基因干细胞移植后的安全性初步结果。
Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7164s-7170s. doi: 10.1158/1078-0432.CCR-1004-0018.
9
Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapse.分次给予吉妥珠单抗奥佐米星联合 3+7 诱导化疗作为首次复发的年轻急性髓系白血病患者的挽救治疗。
Ann Hematol. 2012 Dec;91(12):1871-7. doi: 10.1007/s00277-012-1528-9. Epub 2012 Jul 21.
10
A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia.阿扎胞苷联合吉妥珠单抗奥唑米星治疗复发性急性髓系白血病的 I/II 期临床试验。
Clin Lymphoma Myeloma Leuk. 2018 May;18(5):346-352.e5. doi: 10.1016/j.clml.2018.02.017. Epub 2018 Mar 2.

引用本文的文献

1
Pharmacological Maintenance Therapies After Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植后的药物维持治疗
Adv Exp Med Biol. 2025;1475:193-207. doi: 10.1007/978-3-031-84988-6_11.
2
Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients.TP53 突变型急性髓系白血病和骨髓增生异常综合征的移植结局：一家移植中心 63 例患者的经验
Int J Hematol. 2025 Jun;121(6):820-832. doi: 10.1007/s12185-025-03951-z. Epub 2025 Feb 26.
3
Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
可测量残留病在接受异基因造血细胞移植治疗急性髓系白血病患者中的意义
Cells. 2025 Feb 15;14(4):290. doi: 10.3390/cells14040290.
4
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.氟达拉滨/美法仑（FM140）与氟达拉滨/美法仑/卡莫司汀（FBM110）用于接受异基因造血细胞移植的复发/难治性急性髓系白血病患者的比较——一项代表欧洲血液和骨髓移植协会急性白血病工作组开展的注册研究
Bone Marrow Transplant. 2025 Mar;60(3):373-379. doi: 10.1038/s41409-024-02499-6. Epub 2024 Dec 19.
5
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies.阿扎胞苷和吉妥珠单抗奥佐米星作为高危血液恶性肿瘤移植后的维持治疗。
Bone Marrow Transplant. 2024 Aug;59(8):1169-1175. doi: 10.1038/s41409-024-02311-5. Epub 2024 May 23.
6
Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapy.异基因造血干细胞移植后急性髓系白血病的移植后维持治疗，包括靶向治疗、免疫治疗和细胞治疗等多种治疗方式的协调。
Int J Hematol. 2023 Jul;118(1):1-17. doi: 10.1007/s12185-023-03614-x. Epub 2023 May 22.
7
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes: The Current Landscape and Future Directions.骨髓增生异常综合征的造血干细胞移植：现状与未来方向。
Cancer J. 2023;29(3):179-187. doi: 10.1097/PPO.0000000000000662.
8
Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS.克服复发：AML 或 MDS 患者异基因移植后使用阿扎胞苷或 FLT3 抑制剂进行预防或先发治疗。
Int J Hematol. 2023 Aug;118(2):169-182. doi: 10.1007/s12185-023-03596-w. Epub 2023 Apr 10.
9
The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in Children.儿童造血干细胞移植后非感染性并发症新药物的研发
J Clin Med. 2023 Mar 9;12(6):2149. doi: 10.3390/jcm12062149.
10
Commentary: Maintenance with hypomethylating agents after allogeneic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis.述评：急性髓系白血病和骨髓增生异常综合征异基因干细胞移植后使用去甲基化药物维持治疗：一项系统评价和荟萃分析。
Front Med (Lausanne). 2022 Oct 31;9:1051526. doi: 10.3389/fmed.2022.1051526. eCollection 2022.